(Q40390092)

English

Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

Hirokazu Kanegane

10

object named as

Hirokazu Kanegane

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Keiichi Hirono

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yasushi Kemmotsu

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Helmut Wittkowski

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dirk Foell

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kazuyoshi Saito

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Keijirou Ibuki

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kazuhiro Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sayaka Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Keiichirou Uese

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hideki Origasa

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Fukiko Ichida

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Johhanes Roth

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Toshio Miyawaki

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tsutomu Saji

15

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pediatric Research

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

696-701

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Resistance to intravenous immunoglobulin in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Kawasaki disease: an overview

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

S100A12 (EN-RAGE) in monitoring Kawasaki disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Gene Expression Profiling of the Effect of High-Dose Intravenous Ig in Patients with Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell li

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31819ED68D

21 January 2018

Identifiers

10.1203/PDR.0B013E31819ED68D

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40390092&oldid=2203652713"